Cryofocus Medtech (Shanghai) Co (HKSE:06922) Total Assets : HK$198.78 Mil (As of Jun. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Cryofocus Medtech (Shanghai) Co Total Assets?

Cryofocus Medtech (Shanghai) Co's Total Assets for the quarter that ended in Jun. 2024 was HK$198.78 Mil.

During the past 12 months, Cryofocus Medtech (Shanghai) Co's average Total Assets Growth Rate was 16.00% per year. During the past 3 years, the average Total Assets Growth Rate was 34.60% per year.

During the past 5 years, Cryofocus Medtech (Shanghai) Co's highest 3-Year average Total Assets Growth Rate was 34.60%. The lowest was 34.60%. And the median was 34.60%.

Total Assets is connected with ROA %. Cryofocus Medtech (Shanghai) Co's annualized ROA % for the quarter that ended in Jun. 2024 was -52.06%. Total Assets is also linked to Revenue through Asset Turnover. Cryofocus Medtech (Shanghai) Co's Asset Turnover for the quarter that ended in Jun. 2024 was 0.10.

Cryofocus Medtech (Shanghai) Co Total Assets Historical Data

The historical data trend for Cryofocus Medtech (Shanghai) Co's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cryofocus Medtech (Shanghai) Co Total Assets Chart

Cryofocus Medtech (Shanghai) Co Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Dec24

Total Assets

88.15

283.70

350.50

232.78

159.35

Cryofocus Medtech (Shanghai) Co Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Total Assets	Get a 7-Day Free Trial			350.50	280.75	232.78	198.78	159.35

Cryofocus Medtech (Shanghai) Co Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Cryofocus Medtech (Shanghai) Co's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (A: Dec. 2023 )	+	Total Liabilities (A: Dec. 2023 )
	=	189.727	+	43.052
	=	232.78

Cryofocus Medtech (Shanghai) Co's Total Assets for the quarter that ended in Jun. 2024 is calculated as

Total Assets	=	Total Equity (Q: Jun. 2024 )	+	Total Liabilities (Q: Jun. 2024 )
	=	135.675	+	63.104
	=	198.78

Cryofocus Medtech (Shanghai) Co (HKSE:06922) Total Assets Explanation

Total Assets is connected with ROA %.

Cryofocus Medtech (Shanghai) Co's annualized ROA % for the quarter that ended in Jun. 2024 is

ROA %	=	Net Income (Q: Jun. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Jun. 2024 ))	/ count )
	=	-112.328	/	( (232.779	+	198.778)	/ 2 )
	=	-112.328	/	215.7785
	=	-52.06 %

Note: The Net Income data used here is two times the semi-annual (Jun. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Cryofocus Medtech (Shanghai) Co's Asset Turnover for the quarter that ended in Jun. 2024 is

	Asset Turnover
=	Revenue (Q: Jun. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Jun. 2024 ))	/ count )
=	20.966	/	( (232.779	+	198.778)	/ 2 )
=	20.966	/	215.7785
=	0.10

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Cryofocus Medtech (Shanghai) Co Total Assets Related Terms

Thank you for viewing the detailed overview of Cryofocus Medtech (Shanghai) Co's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Cryofocus Medtech (Shanghai) Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cryofocus Medtech (Shanghai) Co Ltd (HKSE:06922) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

Lane 3399, Kangxin Road, Building 15, Pudong New Area, Shanghai, CHN, 200120

Website

https://www.cryofocus.com

Cryofocus Medtech (Shanghai) Co Ltd is a medical device company engaged in the research and development, manufacture, and sale of cryoablation minimally invasive interventional treatment technology and related medical products. The products offered by the company include; Bladder Cryoablation System, Pulmonary Nodule Localization Needle, and Endoscopic Clip for Anastomosis among others. Geographically, the company's revenue is generated from the sale of medical consumables and devices in the Chinese Mainland.

Executives

Zhuhai Junheng Investment L.p. (limited Partnership)	2101 Beneficial owner
Shang Hai Shi Di Sheng Wu Ke Ji You Xian Gong Si
Lv Shiwen	2103 Interests held jointly with another person
Shenzhen Gao Ling Tiancheng Iii Investment Co., Ltd.	2201 Interest of corporation controlled by you
Ning Bo Lin Feng Sheng Wu Ke Ji You Xian Gong Si
Wu Jianhui	2101 Beneficial owner
Li Hui	2202 Interest of your spouse
Shang Hai Shi Di Shi Ye Fa Zhan You Xian Gong Si
Sun Xiaolu	2201 Interest of corporation controlled by you
Fu Guo Ji Jin Guan Li You Xian Gong Si	2102 Investment manager
Hang Zhou Bi Lin Xing Chuang Xin Tou Zi He Huo Qi Ye You Xian He Huo
Shang Hai Bi Lin Xing Zi Chan Guan Li You Xian Gong Si
Hang Zhou Bi Lin Xing Chuang Xin Tou Zi Guan Li He Huo Qi Ye You Xian He Huo
Sheng Shan Zi Chan Guan Li Shang Hai You Xian Gong Si
Gan Shi Xiong

Cryofocus Medtech (Shanghai) Co Headlines

No Headlines